help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujimoto, J.
Right arrow Articles by Tamaya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujimoto, J.
Right arrow Articles by Tamaya, T.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 1 359-362
Copyright © 1999 by The Endocrine Society


Original Studies

Expression of Platelet-Derived Endothelial Cell Growth Factor (PD-ECGF) Related to Angiogenesis in Ovarian Endometriosis

Jiro Fujimoto, Hideki Sakaguchi, Reiko Hirose and Teruhiko Tamaya

Department of Obstetrics and Gynecology, Gifu University School of Medicine, Gifu City 500-8705, Japan

Address all correspondence and requests for reprints to: Jiro Fujimoto, M.D., Ph.D., Department of Obstetrics and Gynecology, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu City 500-8705, Japan.

Platelet-derived endothelial cell growth factor (PD-ECGF) is expressed in the lining epithelial cells of ovarian endometriomas, and in interstitial cells of the subepithelial area with angiogenesis. The expression of PD-ECGF persists in endometriotic endometrium during the menstrual cycle. This might suggest that PD-ECGF contributes to the growth of ovarian endometriomas via subepithelial angiogenesis independently of the sex steroidal milieu.




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Zhang, N. Dmitrieva, Y. Liu, K. A. McGinty, and K. J. Berkley
Endometriosis as a neurovascular condition: estrous variations in innervation, vascularization, and growth factor content of ectopic endometrial cysts in the rat
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R162 - R171.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
M. W. Laschke and M. D. Menger
In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis
Hum. Reprod. Update, July 1, 2007; 13(4): 331 - 342.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. M. Becker, R. D. Wright, R. Satchi-Fainaro, T. Funakoshi, J. Folkman, A. L. Kung, and R. J. D'Amato
A Novel Noninvasive Model of Endometriosis for Monitoring the Efficacy of Antiangiogenic Therapy
Am. J. Pathol., June 1, 2006; 168(6): 2074 - 2084.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.W. Laschke, A. Elitzsch, B. Vollmar, P. Vajkoczy, and M.D. Menger
Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions
Hum. Reprod., January 1, 2006; 21(1): 262 - 268.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Kats, C. N. Metz, and A. Akoum
Macrophage Migration Inhibitory Factor Is Markedly Expressed in Active and Early-Stage Endometriotic Lesions
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 883 - 889.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. L. Alcazar
Transvaginal colour Doppler in patients with ovarian endometriomas and pelvic pain
Hum. Reprod., December 1, 2001; 16(12): 2672 - 2675.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Fujimoto, H. Sakaguchi, I. Aoki, and T. Tamaya
The Value of Platelet-derived Endothelial Cell Growth Factor as a Novel Predictor of Advancement of Uterine Cervical Cancers
Cancer Res., July 1, 2000; 60(13): 3662 - 3665.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
J. Fujimoto, H. Sakaguchi, R. Hirose, H. Wen, and T. Tamaya
Clinical Implication of Expression of Platelet-derived Endothelial Cell Growth Factor (PD-ECGF) in Metastatic Lesions of Uterine Cervical Cancers
Cancer Res., July 1, 1999; 59(13): 3041 - 3044.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society